Menu
Not yet recruiting NCT07644130

Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive Disorder

No phase Interventional Obsessive Compulsive Disorder (OCD)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Bergen Four-Day Treatment (B4DT).
Who it may be relevant to
Registry conditions: Obsessive Compulsive Disorder (OCD). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The aim of this study is to expand access to Bergen Four-Day Treatment (B4DT) in Finland and to integrate it into psychiatric care pathways at Tampere University Hospital (TAYS). A Bergen team has been established within TAYS Psychiatry and has been trained in collaboration with the B4DT team from HUS and the Norwegian developers. The objective of this study is to enhance understanding of the model's adaptability to the Finnish healthcare system, evaluate healthcare professionals' attitudes toward the intervention, and assess treatment outcomes. The aim is to recruit approximately 35 patients for the study. Patients will be recruited from a minimum of three groups (15 patients) and up to a maximum of six groups (35 patients). The criteria for admission to B4DT and for participation in the study are identical. The treatment and the study may include patients receiving specialized psychiatric care at Tampere University Hospital who have been diagnosed with obsessive-compulsive disorder and who experience significant impairment due to their symptoms. In addition, personnel from TAYS Psychiatry who recommend and refer patients for B4DT will be recruited for the study. The estimated number of participating staff members is approximately 30.

Interventions

  • Other Bergen Four-Day Treatment (B4DT)
    The intervention starts with a pre-assessment, during which patients' motivation, expectations, and willingness to engage in exposure practice are assessed. After the pre-assessment, patients participate in a four-day intensive treatment period based on exposure and response prevention. The intensive phase is an individualized intervention delivered within a group framework. This phase is followed by a three-month period of independent practice, with a couple of appointments with the therapist.

Primary outcome measures

  • Yale-Brown Obsessive-Compulsive Scale, Self-Report (Y-BOCS-SR) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]
  • Obsessive-Compulsive Inventory - Revised (OCI-R) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]
  • Client Satisfaction Questionnaire (CSQ-8) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]
  • Credibility and Expectancy Questionnaire (CEQ) [Time frame: approximately four months]
  • Self-report for healthcare professionals (AIM, IAM, FIM) [Time frame: approximately four months]
Secondary outcome measures (5)
  • Patient Health Questionnaire (PHQ-9) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]
  • Generalized Anxiety Disorder Scale (GAD-7) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]
  • Work and Social Adjustment Scale (WSAS) [Time frame: From pre-assessment to the end of follow-up approximately four to six months]
  • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]
  • EuroQol 5-Dimension Questionnaire (EQ-5D) [Time frame: From pre-assessment to the end of follow-up approximately four to six months.]

Eligibility criteria

Inclusion criteria

  • diagnosed with obsessive-compulsive disorder
  • willingness to participate in exposure-based treatment

Exclusion criteria

  • intellectual disability
  • autism spectrum disorder that precludes engagement in psychotherapeutic work
  • a psychotic disorder with current psychotic symptoms
  • underweight or very rapid weight loss affecting cognition
  • severe suicidality
  • substance dependence
  • benzodiazepine medication (use of Z-drugs as sleep medication is permitted)
  • In addition, ongoing psychotherapy may prevent participating in the B4DT.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Finland · 1 center
  • Tampere University Hospital — Tampere

Identifiers

NCT: NCT07644130 · R26017

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗